The Aubrai scientific project, initiated under Bio Protocol, has successfully launched on the Base network, demonstrating high interest from both the community and investors.
Launch of Aubrai on Base Network
The Aubrai project was announced on the Base network as the first BioAgent project from Bio Protocol in collaboration with VitaDAO and longevity expert Dr. Aubrey de Grey. The launch marked a significant step in decentralized science, combining AI research with blockchain-based funding.
Community Support and Token Sale
Community interest was evident during the Aubrai token sale, which was oversubscribed by 13.5 times. The initial trading volume reached $6.4 million within hours, indicating strong engagement. The initial target for the sale was 234,000 BIO tokens, demonstrating the potential of decentralized systems to attract significant investments.
Impact of Aubrai Model on Scientific Research
Aubrai tokens showed notable price fluctuations, temporarily peaking over $20 million. The project model involves token holders as stakeholders in research outcomes, highlighting potential shifts in research governance and commercial opportunities for future scientific discovery platforms.
The launch of Aubrai represents an important move towards a new model of funding for scientific research that researchers and investors can leverage in the future.
